Medical Care
Global Tuberculosis (TB) Diagnostics Market Research Report 2025
- Jun 28, 25
- ID: 27538
- Pages: 76
- Figures: 79
- Views: 17
The global market for Tuberculosis (TB) Diagnostics was valued at US$ 3070 million in the year 2024 and is projected to reach a revised size of US$ 4149 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO’s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X‑ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives—such as universal healthcare coverage and integrated respiratory disease programs—has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.
Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms—especially in remote rural areas—also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis (TB) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Segment by Application
Diagnostic Laboratories
Hospitals
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO’s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X‑ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives—such as universal healthcare coverage and integrated respiratory disease programs—has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.
Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms—especially in remote rural areas—also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis (TB) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Segment by Application
Diagnostic Laboratories
Hospitals
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2020-2031)
2.2 Global Tuberculosis (TB) Diagnostics Growth Trends by Region
2.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tuberculosis (TB) Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Tuberculosis (TB) Diagnostics Market Dynamics
2.3.1 Tuberculosis (TB) Diagnostics Industry Trends
2.3.2 Tuberculosis (TB) Diagnostics Market Drivers
2.3.3 Tuberculosis (TB) Diagnostics Market Challenges
2.3.4 Tuberculosis (TB) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue
3.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Top Tuberculosis (TB) Diagnostics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tuberculosis (TB) Diagnostics Revenue
3.4 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2024
3.5 Global Key Players of Tuberculosis (TB) Diagnostics Head office and Area Served
3.6 Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application
3.7 Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis (TB) Diagnostics Breakdown Data by Type
4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031)
5 Tuberculosis (TB) Diagnostics Breakdown Data by Application
5.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Market Size (2020-2031)
6.2 North America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
6.4 North America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Diagnostics Market Size (2020-2031)
7.2 Europe Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
7.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Tuberculosis (TB) Diagnostics Market Size (2020-2031)
9.2 Latin America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction
11.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.1.5 Danaher Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Tuberculosis (TB) Diagnostics Introduction
11.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Tuberculosis (TB) Diagnostics Introduction
11.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.4.5 BD Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction
11.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction
11.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.6.5 Hologic Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction
11.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Details
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction
11.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.8.5 BioMerieux Recent Development
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Details
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction
11.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.9.5 Hain Lifescience Recent Development
11.10 Oxford Immunotec
11.10.1 Oxford Immunotec Company Details
11.10.2 Oxford Immunotec Business Overview
11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction
11.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.10.5 Oxford Immunotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2020-2031)
2.2 Global Tuberculosis (TB) Diagnostics Growth Trends by Region
2.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tuberculosis (TB) Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Tuberculosis (TB) Diagnostics Market Dynamics
2.3.1 Tuberculosis (TB) Diagnostics Industry Trends
2.3.2 Tuberculosis (TB) Diagnostics Market Drivers
2.3.3 Tuberculosis (TB) Diagnostics Market Challenges
2.3.4 Tuberculosis (TB) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue
3.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Top Tuberculosis (TB) Diagnostics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tuberculosis (TB) Diagnostics Revenue
3.4 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2024
3.5 Global Key Players of Tuberculosis (TB) Diagnostics Head office and Area Served
3.6 Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application
3.7 Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis (TB) Diagnostics Breakdown Data by Type
4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031)
5 Tuberculosis (TB) Diagnostics Breakdown Data by Application
5.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Market Size (2020-2031)
6.2 North America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
6.4 North America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Diagnostics Market Size (2020-2031)
7.2 Europe Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
7.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Tuberculosis (TB) Diagnostics Market Size (2020-2031)
9.2 Latin America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Details
11.1.2 Danaher Business Overview
11.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction
11.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.1.5 Danaher Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Tuberculosis (TB) Diagnostics Introduction
11.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Tuberculosis (TB) Diagnostics Introduction
11.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.4.5 BD Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction
11.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction
11.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.6.5 Hologic Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction
11.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Details
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction
11.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.8.5 BioMerieux Recent Development
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Details
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction
11.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.9.5 Hain Lifescience Recent Development
11.10 Oxford Immunotec
11.10.1 Oxford Immunotec Company Details
11.10.2 Oxford Immunotec Business Overview
11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction
11.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)
11.10.5 Oxford Immunotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Culture-Based Diagnostics
Table 3. Key Players of Sputum Smear Microscopy
Table 4. Key Players of Rapid Molecular Diagnostics
Table 5. Key Players of Others
Table 6. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Tuberculosis (TB) Diagnostics Market Share by Region (2020-2025)
Table 10. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Tuberculosis (TB) Diagnostics Market Share by Region (2026-2031)
Table 12. Tuberculosis (TB) Diagnostics Market Trends
Table 13. Tuberculosis (TB) Diagnostics Market Drivers
Table 14. Tuberculosis (TB) Diagnostics Market Challenges
Table 15. Tuberculosis (TB) Diagnostics Market Restraints
Table 16. Global Tuberculosis (TB) Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Tuberculosis (TB) Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)
Table 19. Ranking of Global Top Tuberculosis (TB) Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Tuberculosis (TB) Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application
Table 23. Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Danaher Company Details
Table 49. Danaher Business Overview
Table 50. Danaher Tuberculosis (TB) Diagnostics Product
Table 51. Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Danaher Recent Development
Table 53. Roche Company Details
Table 54. Roche Business Overview
Table 55. Roche Tuberculosis (TB) Diagnostics Product
Table 56. Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Thermo Fisher Scientific Company Details
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product
Table 61. Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. BD Company Details
Table 64. BD Business Overview
Table 65. BD Tuberculosis (TB) Diagnostics Product
Table 66. BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 67. BD Recent Development
Table 68. Abbott Company Details
Table 69. Abbott Business Overview
Table 70. Abbott Tuberculosis (TB) Diagnostics Product
Table 71. Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Abbott Recent Development
Table 73. Hologic Company Details
Table 74. Hologic Business Overview
Table 75. Hologic Tuberculosis (TB) Diagnostics Product
Table 76. Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Hologic Recent Development
Table 78. Qiagen Company Details
Table 79. Qiagen Business Overview
Table 80. Qiagen Tuberculosis (TB) Diagnostics Product
Table 81. Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Qiagen Recent Development
Table 83. BioMerieux Company Details
Table 84. BioMerieux Business Overview
Table 85. BioMerieux Tuberculosis (TB) Diagnostics Product
Table 86. BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 87. BioMerieux Recent Development
Table 88. Hain Lifescience Company Details
Table 89. Hain Lifescience Business Overview
Table 90. Hain Lifescience Tuberculosis (TB) Diagnostics Product
Table 91. Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Hain Lifescience Recent Development
Table 93. Oxford Immunotec Company Details
Table 94. Oxford Immunotec Business Overview
Table 95. Oxford Immunotec Tuberculosis (TB) Diagnostics Product
Table 96. Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Oxford Immunotec Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Tuberculosis (TB) Diagnostics Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Culture-Based Diagnostics Features
Figure 5. Sputum Smear Microscopy Features
Figure 6. Rapid Molecular Diagnostics Features
Figure 7. Others Features
Figure 8. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Tuberculosis (TB) Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 13. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Tuberculosis (TB) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Tuberculosis (TB) Diagnostics Market Share by Region: 2024 VS 2031
Figure 16. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 17. Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2024
Figure 19. North America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)
Figure 21. United States Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)
Figure 25. Germany Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Tuberculosis (TB) Diagnostics Market Share by Region (2020-2031)
Figure 33. China Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)
Figure 41. Mexico Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)
Figure 45. Israel Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Danaher Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 51. BD Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 53. Hologic Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 54. Qiagen Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 55. BioMerieux Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 56. Hain Lifescience Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 57. Oxford Immunotec Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Culture-Based Diagnostics
Table 3. Key Players of Sputum Smear Microscopy
Table 4. Key Players of Rapid Molecular Diagnostics
Table 5. Key Players of Others
Table 6. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Tuberculosis (TB) Diagnostics Market Share by Region (2020-2025)
Table 10. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Tuberculosis (TB) Diagnostics Market Share by Region (2026-2031)
Table 12. Tuberculosis (TB) Diagnostics Market Trends
Table 13. Tuberculosis (TB) Diagnostics Market Drivers
Table 14. Tuberculosis (TB) Diagnostics Market Challenges
Table 15. Tuberculosis (TB) Diagnostics Market Restraints
Table 16. Global Tuberculosis (TB) Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Tuberculosis (TB) Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)
Table 19. Ranking of Global Top Tuberculosis (TB) Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Tuberculosis (TB) Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application
Table 23. Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Danaher Company Details
Table 49. Danaher Business Overview
Table 50. Danaher Tuberculosis (TB) Diagnostics Product
Table 51. Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Danaher Recent Development
Table 53. Roche Company Details
Table 54. Roche Business Overview
Table 55. Roche Tuberculosis (TB) Diagnostics Product
Table 56. Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Thermo Fisher Scientific Company Details
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product
Table 61. Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. BD Company Details
Table 64. BD Business Overview
Table 65. BD Tuberculosis (TB) Diagnostics Product
Table 66. BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 67. BD Recent Development
Table 68. Abbott Company Details
Table 69. Abbott Business Overview
Table 70. Abbott Tuberculosis (TB) Diagnostics Product
Table 71. Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Abbott Recent Development
Table 73. Hologic Company Details
Table 74. Hologic Business Overview
Table 75. Hologic Tuberculosis (TB) Diagnostics Product
Table 76. Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Hologic Recent Development
Table 78. Qiagen Company Details
Table 79. Qiagen Business Overview
Table 80. Qiagen Tuberculosis (TB) Diagnostics Product
Table 81. Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Qiagen Recent Development
Table 83. BioMerieux Company Details
Table 84. BioMerieux Business Overview
Table 85. BioMerieux Tuberculosis (TB) Diagnostics Product
Table 86. BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 87. BioMerieux Recent Development
Table 88. Hain Lifescience Company Details
Table 89. Hain Lifescience Business Overview
Table 90. Hain Lifescience Tuberculosis (TB) Diagnostics Product
Table 91. Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Hain Lifescience Recent Development
Table 93. Oxford Immunotec Company Details
Table 94. Oxford Immunotec Business Overview
Table 95. Oxford Immunotec Tuberculosis (TB) Diagnostics Product
Table 96. Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Oxford Immunotec Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Tuberculosis (TB) Diagnostics Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Culture-Based Diagnostics Features
Figure 5. Sputum Smear Microscopy Features
Figure 6. Rapid Molecular Diagnostics Features
Figure 7. Others Features
Figure 8. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Tuberculosis (TB) Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 13. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Tuberculosis (TB) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Tuberculosis (TB) Diagnostics Market Share by Region: 2024 VS 2031
Figure 16. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2024
Figure 17. Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2024
Figure 19. North America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)
Figure 21. United States Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)
Figure 25. Germany Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Tuberculosis (TB) Diagnostics Market Share by Region (2020-2031)
Figure 33. China Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)
Figure 41. Mexico Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)
Figure 45. Israel Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Danaher Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 51. BD Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 53. Hologic Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 54. Qiagen Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 55. BioMerieux Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 56. Hain Lifescience Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 57. Oxford Immunotec Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232